Utilizing Patient-Derived Epithelial Ovarian Cancer Tumor Organoids to Predict Carboplatin Resistance

The development of patient-derived tumor organoids (TOs) from an epithelial ovarian cancer tumor obtained at the time of primary or interval debulking surgery has the potential to play an important role in precision medicine. Here, we utilized TOs to test front-line chemotherapy sensitivity and to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorski, Justin W., Zhang, Zhuwei, McCorkle, J. Robert, DeJohn, Jodi M., Wang, Chi, Miller, Rachel W., Gallion, Holly H., Dietrich, Charles S., Ueland, Frederick R., Kolesar, Jill M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394135/
https://www.ncbi.nlm.nih.gov/pubmed/34440225
http://dx.doi.org/10.3390/biomedicines9081021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394135/
https://www.ncbi.nlm.nih.gov/pubmed/34440225
http://dx.doi.org/10.3390/biomedicines9081021

Ejemplares similares